Genetic Insights into Sepsis: What have we Learned and How will it Help?

E-ISSN： 1873-4286|14|19|1900-1911

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.14, Iss.19, 2008-07, pp. : 1900-1911

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Myc - What We have Learned from Flies

Current Drug Targets, Vol. 10, Iss. 7, 2009-07 ,pp. : 590-601

Bentham Science Publishers

Access to resources Recommend Favorite

On the Pathogenesis and Neuroprotective Treatment of Parkinson Disease: What have we Learned from the Genetic Forms of this Disease?

Current Medicinal Chemistry, Vol. 15, Iss. 23, 2008-10 ,pp. : 2305-2320

Bentham Science Publishers

Access to resources Recommend Favorite

Dictyostelium genomics: how it developed and what we have learned from it

By Noegel A. A. Glöckner G.

Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol. 68, Iss. 7, 2013-07 ,pp. : 474-477

Govi-Verlag

Access to resources Recommend Favorite

Genetic basis of susceptibility to drug-induced liver injury: what have we learned and where do we go from here?

By Urban Thomas J Goldstein David B Watkins Paul B

Pharmacogenomics, Vol. 13, Iss. 7, 2012-05 ,pp. : 735-738

Future Medicine

Access to resources Recommend Favorite

CCR1 Antagonists: What Have We Learned From Clinical Trials

Current Topics in Medicinal Chemistry, Vol. 10, Iss. 13, 2010-09 ,pp. : 1268-1277

Bentham Science Publishers

Access to resources Recommend Favorite